Serum levels of interleukin-1 beta associate better with severity of simple steatosis than liver function tests in morbidly obese patients
Background: In high-fat diet-fed mice, interleukin-1 beta (IL-1 beta) has been shown to play a key role in hepatic steatosis. However, it remains unknown whether IL-1 beta could be associated with different grades of steatosis in obese humans. Materials and Methods: Morbidly obese patients (n = 124)...
Main Authors: | Leon F Palomera, Angélica Y Gómez-Arauz, Eréndira Villanueva-Ortega, Guillermo Meléndez-Mier, Sergio A Islas-Andrade, Galileo Escobedo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Journal of Research in Medical Sciences |
Subjects: | |
Online Access: | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2018;volume=23;issue=1;spage=93;epage=93;aulast=Palomera |
Similar Items
-
Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice
by: Margarita Vida, et al.
Published: (2015-07-01) -
Research progress in association between interleukin-23 and liver diseases
by: BAO Suxia, et al.
Published: (2016-02-01) -
Non-Alcoholic Steatohepatitis (NASH): Risk Factors in Morbidly Obese Patients
by: Alexandre Losekann, et al.
Published: (2015-10-01) -
Changes in serum levels of interleukin-32 and interleukin-10 and their clinical significance in patients with HBV-related acute-on-chronic liver failure
by: GU Jing, et al.
Published: (2018-04-01) -
Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study
by: Kronenberger Bernd, et al.
Published: (2012-09-01)